In vivo models of proliferative vitreoretinopathy

Nature Protocols

Volumn 2, Issue 1, 2007, Pages 67-77

  Agrawal, Rajat N ^a   He, Shikun ^a   Spee, Christine ^a   Cui, Jing Z ^b   Ryan, Stephen J ^a   Hinton, David R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CULTURE; CLINICAL ASSESSMENT; DISEASE CLASSIFICATION; EPITHELIUM CELL; EYE INJURY; EYE PHOTOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PENETRATING TRAUMA; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; REPRODUCIBILITY; RETINA DETACHMENT SURGERY; STANDARDIZATION; TREATMENT FAILURE; ANIMAL; ANIMAL MODEL; CYTOLOGY; FLUORESCENCE ANGIOGRAPHY; INJECTION; METHODOLOGY; PATHOPHYSIOLOGY; RABBIT; VITREORETINOPATHY;

ANIMALS; CELLS, CULTURED; FLUORESCEIN ANGIOGRAPHY; INJECTIONS; MODELS, ANIMAL; PIGMENT EPITHELIUM OF EYE; RABBITS; TOMOGRAPHY, OPTICAL COHERENCE; VITREORETINOPATHY, PROLIFERATIVE;

EID: 34347209972     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2007.4     Document Type: Article

References (81)

1. Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90, 121-125 (1983).
2. Machemer, R. Pathogenesis and classification of massive periretinal proliferation. Br. J. Ophthalmol. 62, 737-747 (1978).
3. Silicone Study Group. Proliferative vitreoretinopathy (Editorial). Am. J. Ophthalmol. 99, 593-595 (1985).
4. Green, W.G. & Sebag, J. Vitreoretinal interface. in Retina 4th edn. Vol. 3 (ed. Ryan, S.J.) 1921-1989 (Elsevier Mosby, St. Louis, 2006).
5. Thompson, J.T. Proliferative vitreoretinopathy. in Retina 4th edn. Vol. 3 (ed. Ryan, S.J.) 2282-2309 (Elsevier Mosby, St. Louis, 2006).
6. Vinores, S.A., Campochiaro, P.A. & Conway, B.P. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest. Ophthalmol. Vis. Sci. 31, 14-28 (1990).
7. Charteris, D.G. Proliferative vitreoretinopathy: Pathobiology, surgical management, and adjunctive treatment. Br. J. Ophthalmol. 79, 953-960 (1995).
8. Weller, M., Esser, P., Bresgen, M., Heimann, K. & Wiedemann, P. Thrombospondin: A new attachment protein in preretinal traction membranes. Eur. J. Ophthalmol. 2, 10-14 (1992).
9. Hiscott, P.S., Grierson, I. & McLeod, D. Natural history of fibrocellular epiretinal membranes: A quantitative, autoradiographic, and immunohistochemical study. Br. J. Ophthalmol. 11, 810-823 (1985).
10. Cordeiro, M.F. et al. Molecular therapy in ocular wound healing. Br. J. Ophthalmol. 83, 1219-1224 (1999).
11. Campochiaro, P.A. Pathogenesis of proliferative vitreoretinopathy. in Retina 3rd edn. Vol. 3 (ed. Ryan, S.J.) 2221-2227 (Mosby, St. Louis, 2001).
12. Thumann, G. & Hinton, D.R. Cell biology of the retinal pigment epithelium. in Retina 3rd edn. Vol. 1 (ed. Ryan, S.J.) 104-121 (Mosby, St. Louis, 2001).
13. Anderson, D.H., Stern, W.H., Fisher, S.K., Erickson, P.A. & Borgula, G.A. The onset of pigment epithelial proliferation after retinal detachment. Invest. Ophthalmol. Vis. Sci. 21, 10-16 (1981).
14. Jin, M., He, S., Worpel, V., Ryan, S.J. & Hinton, D.R. Promotion of adhesion and migration of RPE cells to provisional extracellular matrices by TNF-α. Invest. Ophthalmol. Vis. Sci. 41, 4324-4332 (2000).
15. Hinton, D.R. et al. Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells. Exp. Cell Res. 239, 11-15 (1998).
16. Limb, G.A., Hollifield, R.D., Webster, L., Charteris, D.G. & Chignell, A.H. Soluble TNF receptors in vitreoretinal proliferative disease. Invest. Opthalmol. Vis. Sci. 42, 1586-1591 (2001).
17. Campochiaro, P.A., Sugg, R., Grotendorst, G. & Hjelmeland, L.M. Retinal pigment epithelial cells produce PDGF-like proteins and secrete them into their media. Exp. Eye Res. 49, 217-227 (1989).
18. Andrews, A. et al. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 40, 2683-2689 (1999).
19. Ikuno, Y., Leong, F.L. & Kazlauskas, A. Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor. Invest. Ophthalmol. Vis. Sci. 41, 3107-3116 (2000).
20. Seo, M.S. et al. Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment. Am. J. Pathol. 157, 995-1005 (2000).
21. Guidry, C. Tractional force generation by porcine muller cells development & differential stimulation by growth factors. Invest. Ophthalmol. Vis. Sci. 38, 456-468 (1997).
22. Hardwick, C. et al. Tractional force generation by porcine muller cells stimulation by growth factors in human vitreous. Invest. Ophthalmol. Vis. Sci. 38, 2053-2063 (1997).
23. Pfeffer, B.A., Flanders, K.C., Guerin, C.J., Danielpour, D. & Anderson, D.H. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp. Eye. Res. 59, 323-333 (1994).
24. Connor, T.B. Jr. et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J. Clin. Invest. 83, 1661-1666 (1989).
25. Bornstein, P. Thrombospondins as matricellular modulators of cell function. J. Clin. Invest. 107, 929-934 (2001).
26. Koli, K., Saharinen, J., Hyytiainen, M., Penttinen, C. & Keski-Oja, J. Latency, activation, and binding proteins of TGF-beta. Microsc. Res. Tech. 52, 354-362 (2001).
27. Hinton, D.R., He, S., Jin, M.L., Barron, E. & Ryan, S.J. Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye 16, 422-428 (2002).
28. Forrester, J.V., Docherty, R., Kerr, C. & Lackief, J.M. Cellular proliferation in the vitreous: The use of vitreous explants as a model system. Invest. Ophthalmol. Vis. Sci. 27, 1085-1094 (1986).
29. Gamulescu, M.A. et al. Transforming growth factor beta-2 induced myofibroblastic differentiation of human pigment epithelial cells: regulation by extracellular matrix protein and hepatocyte growth factor. Exp Eye Res. 83, 212-222 (2006).
30. Blumenkranz, M.S. & Hartzer, M.K. The mechanism of action of drugs for the treatment of vitreoretinal scarring. in Retina 2nd edn. Vol. 3 (ed. Ryan, S.J.) 2281-2300 (CV Mosby, St. Louis, 1994).
31. Kimura, H. et al. Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: Feasibility in prevention of proliferative vitreoretinopathy. Hum. Gene Ther. 7, 799-808 (1996).
32. Lean, J.S., van der Zee, W.A.M. & Ryan, S.J. Experimental model of proliferative vitreoretinopathy (PVR) in the vitrectomized eye: Effect of silicone oil. Br. J. Ophthalmol 68, 332-335 (1984).
33. Allamby, D., Foreman, D., Carrington, L., McLeod, D. & Boulton, M. Cell attachment to, and contraction of, the retina in vitro. Invest. Ophthalmol. Vis. Sci. 38, 2064-2072 (1997).
34. Luo, J. & Miller, M.W. Platelet-derived growth factor-mediated signal transduction underlying astrocyte proliferation: Site of ethanol action. J. Neurosci. 19, 10014-10125 (1999).
35. Fujisawa, K., Spee, C., Hinton, D.R. & Ryan, S.J. PDGF-BB stimulates gliosis in a mouse organ culture model of PVR. Invest. Ophthalmol. Vis. Sci. 44 ARVO E-Abstract 4982 (2003).
36. de Souza, O.F. et al. Inhibition of experimental proliferative vitreoretinopathy in rabbits by suramin. Ophthalmologica 209 212-216 (1995).
37. Fastenberg, D.M., Diddie, K.R., Sorgente, N. & Ryan, S.J. A comparison of different cellular innocula in an experimental model of massive periretinal proliferation. Am. J. Ophthalmol. 93, 559-564 (1982).
38. Fastenberg, D.M., Diddie, K.R., Dorey, K. & Ryan, S.J. The role of cellular proliferation in an experimental model of massive periretinal proliferation. Am. J. Ophthalmol. 93, 565-572 (1982).
39. Wiedermann, P., Sorgente, S. & Ryan, S. Proliferative vitreoretinopathy: The rabbit cell injection model for screening of antiproliferative drugs. J. Pharmacol. Methods 12, 69-78 (1984).
40. Tano, Y., Sigita, G., Abrams, G. & Machemer, R. Inhibition of intraocular proliferation with intravitreal proliferations with intravitreal corticosteroids. Am. J. Ophthalmol. 89, 131-136 (1980).
41. Hida, T., Chandler, D.B. & Sheta, S.M. Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye. Graefes Arch. Clin. Exp. Ophthalmol. 225, 303-307 (1987).
42. Hsu, H.T., Dorey, K., Sorgente, N. & Ryan, S.J. Surgical removal of vitreous. Its effect on intraocular fibroblast proliferation in the vitreous. Arch. Ophthalmol. 102, 605-607 (1984).
43. Sugita, G. et al. Intravitreal autotransplantation of fibroblasts. Am. J. Ophthalmol. 89, 121-130 (1980).
44. Radtke, N.D., Tano, Y., Chandler, D. & Machemer, R. Simulation of massive periretinal proliferation by autotransplantation of retinal pigment cells in rabbits. Am. J. Ophthalmol. 91, 76-87 (1981).
45. Yeo, J.H., Sadeghi, J., Campochiaro, P.A., Green, W.R. & Glaser, B.M. Intravitreous fibronectin and platelet-derived growth factor. Arch. Ophthalmol. 104, 417-421 (1986).
46. Cleary, P.E. & Ryan, S.J. Method of production and natural history of experimental posterior penetrating eye injury in the rhesus monkey. Am. J. Ophthalmol. 88, 212-220 (1979).
47. Wilson, C.A., Khawly, J.A., Hatchell, D.L. & Machemer, R. Experimental traction retinal detachment in the cat. Graefes Arch. Clin. Exp. Ophthalmol. 229, 568-573 (1991).
48. Valeria Canto, S.M., Gallo, J.E., Dodds, R.A. & Suburo, A.M. A mouse model of proliferative vitreoretinopathy induced by dispase. Exp. Eye. Res. 75, 491-504 (2002).
49. Vergara, O., Ogden, T. & Ryan, S.J. Posterior penetrating injury to the rabbit eye: Effect of blood and ferrous ions. Exp. Eye. Res. 49 1115-1126 (1989).
50. Cardillo, J.A. et al. Post-traumatic proliferative vitreoretinopathy: The epidemiologic profile, onset, risk factors and visual outcome. Ophthalmology 104, 1166-1173 (1997).
51. Hsu, H.T. & Ryan, S.J. Natural history of penetrating ocular injury with retinal laceration in the monkey. Graefes Arch. Clin. Exp. Ophthalmol. 224, 1-6 (1986).
52. Cleary, P.E. & Ryan, S.J. Experimental posterior penetrating eye injury in the rabbit: 1. Method of production and natural history. Br. J. Ophthalmol. 63, 306-311 (1979).
53. Cleary, P.E. & Ryan, S.J. Experimental posterior penetrating eye injury in the rabbit. II. Histology of wound, vitreous, and retina. Br. J. Ophthalmol. 63, 312-321 (1979).
54. Cleary, P.E. & Ryan, S.J. Vitrectomy in penetrating eye injury. Results of a controlled trial of vitrectomy in an experimental posterior penetrating eye injury in the rhesus monkey. Arch. Ophthalmol. 99, 287-292 (1981).
55. Kimura, H. et al. Cellular response in subretinal neovascularization induced by bFGF-impregnated microspheres. Invest. Ophthalmol. Vis. Sci. 40, 524-528 (1999).
56. Latendresse, J.R., Warbrittion, A.R., Jonassen, H. & Creasy, D.M. Fixation of testes and eyes using a modified Davidson's fluid: comparison with Bouin's fluid and conventional Davidson's fluid. Toxicol. Pathol. 30, 524-533 (2002).
57. Algvere, P. & Kock, E. Experimental fibroplasia in the rabbit vitreous. Retinal detachment induced by autologous fibroblasts. Albrecht von Graefes Arch. Klin. Exp. Ophthalmol. 199, 215-222 (1976).
58. Gonvers, M. & Thrasher, R. Temporary use of silicone oil in the treatment of proliferative vitreoretinopathy: An experimental study with a new animal model. Graefes Arch. Clin. Exp. Ophthalmol. 221 46-53 (1983).
59. Chandler, D.B., Quansah, F.A., Hida, T. & Machemer, R. A refined experimental model for proliferative vitreoretinopathy. Graefes Arch. Clin. Exp. Ophthalmol. 224, 86-91 (1986).
60. Sakamoto, T. et al. Inhibition of experimental proliferative vitreoretinopathy by retroviral vector-mediated transfer of suicide gene. Ophthalmology 102, 1417-1424 (1995).
61. Wong, C.A. et al. Induction of proliferative vitreoretinopathy by a unique line of human retinal pigment epithelial cells. Can. J. Ophthalmol. 37, 211-220 (2002).
62. Hui, Y.N., Sorgente, N. & Ryan, S.J. Posterior vitreous separation and retinal detachment induced by macrophages. Graefes Arch. Clin. Exp. Ophthalmol. 225, 279-284 (1987).
63. Hui, Y.N., Goodnight, R., Sorgente, N. & Ryan, S.J. Fibrovascular proliferation and retinal detachment after intravitreal injection of activated macrophages in the rabbit eye. Am. J. Ophthalmol. 108 176-184 (1989).
64. Nakagawa, M., Refojo, M.F., Marin, J.F., Doi, M. & Tolentino, F.I. Retinoic acid in silicone and silicone-fluorosilicone copolymer oils in a rabbit model of proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 36, 2388-2395 (1995).
65. Pinon, R.M. et al. Intravitreal and subretinal proliferation induced by platelet-rich plasma injection in rabbits. Curr. Eye Res. 11, 1047-1055 (1992).
66. Goldaracena, M.B. et al. The role of retinotomy in an experimental rabbit model of proliferative vitreoretinopathy. Curr. Eye Res. 16, 422-427 (1997).
67. Pastor, J.C., Rodriguez, E., Marcos, M.A. & Lopez, M.I. Combined pharmacologic therapy in a rabbit model of proliferative vitreoretinopathy. Ophthalmic Res. 32, 25-29 (2000).
68. Garcia-Layana, A., Pastor, J.C., Saornil, M.A. & Gonzalez, G. Porcine model of proliferative vitreoretinopathy with platelets. Curr. Eye. Res. 16, 556-563 (1997).
69. Chinn, C., Spee, C., Barron, E., Ryan, S.J. & Hinton, D.R. Strain-dependent gene expression in a lens extraction PVR model. Invest. Ophthlamol. Vis. Sci. 46 ARVO E-Abstract 5528 (2005).
70. Saika, S. et al. Inhibition of p38MAP kinase suppresses fibrotic reaction of retinal pigment epithelial cells. Lab. Invest. 85 838-850 (2005).
71. Saika, S. et al. Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in mice. Lab. Invest. 84, 1245-1258 (2004).
72. Campochiaro, P.A., Gaskin, H.C. & Vinores, S.A. Retinal cryopexy stimulates traction retinal detachment formation in the presence of an ocular wound. Arch. Ophthalmol. 105, 1567-1570 (1987).
73. Liou, G.I. et al. HGF regulation of RPE proliferation in an IL-1 beta/retinal hole-induced rabbit model of PVR. Mol. Vis. 8, 494-501 (2002).
74. Planck, S.R. et al. Expression of growth factor mRNA in rabbit PVR model systems. Curr. Eye. Res. 11, 1031-1039 (1992).
75. Frenzel, E.M., Neely, K.A., Walsh, A.W., Cameron, J.D. & Gregerson, D.S. A new model of proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 39, 2157-2164 (1998).
76. Kralinger, M.T. et al. Experimental model for proliferative vitreoretinopathy by intravitreal dispase: Limited by zonulysis and cataract. Ophthalmologica 220, 211-216 (2006).
77. Yamada, H. et al. Platelet-derived growth factor-A-induced retinal gliosis protects against ischemic retinopathy. Am. J. Pathol. 156, 477-487 (2000).
78. Campochiaro, P.A., Hackett, S.F. & Vinores, S.A. Growth factors in the retina and retinal pigmented epithelium. Prog. Retinal Eye Res. 15, 547-567 (1996).
79. Akiyama, H. et al. Intraocular injection of an aptamer that binds PDGF-B: A potential treatment for proliferative retinopathies. J. Cell Physiol. 207, 407-412 (2006).
80. Jin, M., Chen, Y., He, S., Ryan, S.J. & Hinton, D.R. Hepatocyte growth factor and its role in the pathogenesis of retinal detachment. Invest. Ophthalmol. Vis. Sci. 45, 323-329 (2004).
81. Blumenkranz, M.S., Ophir, A., Claflin, A.J. & Kajek, A. Fluorouracil for the treatment of massive preretinal proliferation. Am. J. Ophthalmol. 94, 458-467 (1982).